{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:35:28Z","timestamp":1788824128250,"version":"build-2803163510"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s40123-025-01094-2","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T05:34:48Z","timestamp":1738560888000},"page":"573-584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Use of an Eyelid Pressure Patch Concomitantly with a Decellularized Dehydrated Amniotic Membrane for Ocular Surface Disease Management"],"prefix":"10.1007","volume":"14","author":[{"given":"Kyle","family":"Linsey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"1094_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jtos.2014.10.003","volume":"13","author":"Y-Y Leong","year":"2015","unstructured":"Leong Y-Y, Tong L. Barrier function in the ocular surface: from conventional paradigms to new opportunities. Ocul Surf. 2015;13:103\u20139.","journal-title":"Ocul Surf"},{"key":"1094_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4103\/tjo.tjo_5_20","volume":"10","author":"OG Mead","year":"2020","unstructured":"Mead OG, Tighe S, Tseng SCG. Amniotic membrane transplantation for managing dry eye and neurotrophic keratitis. Taiwan J Ophthalmol. 2020;10:13\u201321.","journal-title":"Taiwan J Ophthalmol"},{"key":"1094_CR3","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.2147\/OPTH.S299141","volume":"28","author":"S Maqsood","year":"2021","unstructured":"Maqsood S, Elsawah K, Dhillon N, Soliman S, Laginaf M, Lodhia V, et al. Management of persistent corneal epithelial defects with human amniotic membrane-derived dry matrix. Clin Ophthalmol. 2021;28:2231\u20138.","journal-title":"Clin Ophthalmol"},{"key":"1094_CR4","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.sjopt.2014.06.011","volume":"28","author":"LR Katzman","year":"2014","unstructured":"Katzman LR, Jeng BH. Management strategies for persistent epithelial defects of the cornea. Saudi J Ophthalmol. 2014;28:168\u201372.","journal-title":"Saudi J Ophthalmol"},{"key":"1094_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.preteyeres.2015.07.002","volume":"49","author":"AV Ljubimov","year":"2015","unstructured":"Ljubimov AV, Saghizadeh M. Progress in corneal wound healing. Prog Retin Eye Res. 2015;49:17\u201345.","journal-title":"Prog Retin Eye Res"},{"key":"1094_CR6","doi-asserted-by":"publisher","first-page":"e396","DOI":"10.1111\/aos.14953","volume":"100","author":"M Rodr\u00edguez Calvo-de-Mora","year":"2022","unstructured":"Rodr\u00edguez Calvo-de-Mora M, Dom\u00ednguez-Ruiz C, Barrero-Sojo F, Rodr\u00edguez-Moreno G, Ant\u00fanez Rodr\u00edguez C, Ponce Verdugo L, et al. Autologous versus allogeneic versus umbilical cord sera for the treatment of severe dry eye disease: a double-blind randomized clinical trial. Acta Ophthalmol. 2022;100:e396\u2013408.","journal-title":"Acta Ophthalmol"},{"key":"1094_CR7","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.3390\/jcm10091939","volume":"10","author":"JM S\u00e1nchez-Gonz\u00e1lez","year":"2021","unstructured":"S\u00e1nchez-Gonz\u00e1lez JM, Alonso-Aliste F, Borroni D, Ami\u00e1n-Cordero J, De-Hita-Cantalejo C, Capote-Puente R, Bautista-Llamas MJ, S\u00e1nchez-Gonz\u00e1lez MC, Rodr\u00edguez-Calvo-de-Mora M, Rocha-de-Lossada C. Plasma rich in growth factors (PRGF) in transepithelial photorefractive keratectomy (TPRK). J Clin Med. 2021;10:1939.","journal-title":"J Clin Med"},{"key":"1094_CR8","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/01.ico.0000151501.80952.c5","volume":"24","author":"M Fernandes","year":"2005","unstructured":"Fernandes M, Sridhar MS, Sangwan VS, et al. Amniotic membrane transplantation for ocular surface reconstruction. Cornea. 2005;24:643\u201353.","journal-title":"Cornea"},{"key":"1094_CR9","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1136\/bjo.85.12.1455","volume":"85","author":"P Prabhasawat","year":"2001","unstructured":"Prabhasawat P, Tesavibul N, Komolsuradej W. Single and multilayer amniotic membrane transplantation for persistent corneal epithelial defect with and without stromal thinning and perforation. Br J Ophthalmol. 2001;85:1455\u201363.","journal-title":"Br J Ophthalmol"},{"key":"1094_CR10","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/archopht.119.5.659","volume":"119","author":"E Letko","year":"2001","unstructured":"Letko E, Stechschulte SU, Kenyon KR, et al. Amniotic membrane inlay and overlay grafting for corneal epithelial defects and stromal ulcers. Arch Ophthalmol. 2001;119:659\u201363.","journal-title":"Arch Ophthalmol"},{"key":"1094_CR11","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1097\/ICO.0b013e3181a2abad","volume":"28","author":"H Sheha","year":"2009","unstructured":"Sheha H, Liang L, Li J, Tseng SC. Sutureless amniotic membrane transplantation for severe bacterial keratitis. Cornea. 2009;28:1118\u201323.","journal-title":"Cornea"},{"key":"1094_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ajoc.2017.06.002","volume":"7","author":"H Sheha","year":"2017","unstructured":"Sheha H, Tighe S, Cheng AM, Tseng SC. A stepping stone in treating dendritic keratitis. Am J Ophthalmol Case Rep. 2017;7:55\u20138.","journal-title":"Am J Ophthalmol Case Rep"},{"key":"1094_CR13","first-page":"243","volume":"108","author":"D Meller","year":"2011","unstructured":"Meller D, Pauklin M, Thomasen H, Westekemper H, Steuhl KP. Amniotic membrane transplantation in the human eye. Dtsch Arztebl Int. 2011;108:243\u20138.","journal-title":"Dtsch Arztebl Int"},{"key":"1094_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ajo.2022.12.007","volume":"251","author":"S Sell","year":"2023","unstructured":"Sell S, de la Presa M, Thakur S, Eslani M, Jeffrey J, Sheppard JD, Holland EJ, Cheung AY. Comparison of persistent epithelial defect treatment with sutureless cryopreserved and dehydrated amniotic membrane. Am J Ophthalmol. 2023;251:32\u201342.","journal-title":"Am J Ophthalmol"},{"key":"1094_CR15","doi-asserted-by":"publisher","DOI":"10.1100\/2012\/815615","volume":"2012","author":"A F\u00fcst","year":"2012","unstructured":"F\u00fcst A, P\u00e1llinger E, St\u00fcndl A, Kov\u00e1cs E, Imre L, T\u00f3th S, N\u00e9meth J. Both freshly prepared and frozen-stored amniotic membrane cells express the complement inhibitor CD59. ScientificWorldJournal. 2012;2012: 815615.","journal-title":"ScientificWorldJournal"},{"issue":"14","key":"1094_CR16","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.2147\/OPTH.S208008","volume":"22","author":"A Walkden","year":"2020","unstructured":"Walkden A. Amniotic membrane transplantation in ophthalmology: an updated perspective. Clin Ophthalmol. 2020;22(14):2057\u201372.","journal-title":"Clin Ophthalmol"},{"key":"1094_CR17","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.3390\/ijms21114029","volume":"21","author":"O Pogozhykh","year":"2020","unstructured":"Pogozhykh O, Hofmann N, Gryshkov O, von Kaisenberg C, Mueller M, et al. Repeated freezing procedures preserve structural and functional properties of amniotic membrane for application in ophthalmology. Int J Mol Sci. 2020;21:4029.","journal-title":"Int J Mol Sci"},{"key":"1094_CR18","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1136\/bjo.83.6.748","volume":"83","author":"HS Dua","year":"1999","unstructured":"Dua HS. Amniotic membrane transplantation. Br J Ophthalmol. 1999;83:748\u201352.","journal-title":"Br J Ophthalmol"},{"key":"1094_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1023\/B:CATB.0000046067.25057.0a","volume":"5","author":"S Burman","year":"2004","unstructured":"Burman S, Tejwani S, Vemuganti GK, et al. Ophthalmic applications of preserved human amniotic membrane: a review of current indications. Cell Tissue Bank. 2004;5:161\u201375.","journal-title":"Cell Tissue Bank"},{"key":"1094_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1477-7827-7-117","volume":"7","author":"NW Thiex","year":"2009","unstructured":"Thiex NW, Chames MC, Loch-Caruso RK. Tissue-specific cytokine release from human extra-placental membranes stimulated by lipopolysaccharide in a two-compartment tissue culture system. Reprod Biol Endocrinol. 2009;7:117.","journal-title":"Reprod Biol Endocrinol"},{"key":"1094_CR21","first-page":"571","volume":"8","author":"M Sacchetti","year":"2014","unstructured":"Sacchetti M, Lambiase A. Diagnosis and management of neurotrophic keratitis. Clin Ophthalmol. 2014;8:571\u20139.","journal-title":"Clin Ophthalmol"},{"key":"1094_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3109\/08820538.2013.768678","volume":"29","author":"E Turkoglu","year":"2014","unstructured":"Turkoglu E, Celik E, Alagoz G. A comparison of the efficacy of autologous serum eye drops with amniotic membrane transplantation in neurotrophic keratitis. Semin Ophthalmol. 2014;29:119\u201326.","journal-title":"Semin Ophthalmol."},{"key":"1094_CR23","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.3390\/jcm10153234","volume":"10","author":"J Lacorzana","year":"2021","unstructured":"Lacorzana J, Campos A, Brocal-S\u00e1nchez M, et al. Visual acuity and number of amniotic membrane layers as indicators of efficacy in amniotic membrane transplantation for corneal ulcers: a multicenter study. J Clin Med. 2021;10:3234.","journal-title":"J Clin Med"},{"key":"1094_CR24","doi-asserted-by":"publisher","first-page":"17008","DOI":"10.1038\/s41598-020-73672-2","volume":"10","author":"HY Yin","year":"2020","unstructured":"Yin HY, Cheng AMS, Tighe S, et al. Self-retained cryopreserved amniotic membrane for treating severe corneal ulcers: a comparative, retrospective control study. Sci Rep. 2020;10:17008.","journal-title":"Sci Rep"},{"key":"1094_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.4103\/0301-4738.33036","volume":"55","author":"VS Sangwan","year":"2007","unstructured":"Sangwan VS, Burman S, Tejwani S, Mahesh SP, Murthy R. Amniotic membrane transplantation: a review of current indications in the management of ophthalmic disorders. Indian J Ophthalmol. 2007;55:251\u201360.","journal-title":"Indian J Ophthalmol"},{"key":"1094_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bjo.2010.184259","volume":"95","author":"VS Sangwan","year":"2011","unstructured":"Sangwan VS, Basu S. Antimicrobial properties of amniotic membrane. Br J Ophthalmol. 2011;95:1\u20132.","journal-title":"Br J Ophthalmol"},{"key":"1094_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/00003226-200201000-00014","volume":"21","author":"N Kobayashi","year":"2002","unstructured":"Kobayashi N, Kabuyama Y, Sasaki S, Kato K, Homma Y. Suppression of corneal neovascularization by culture supernatant of human amniotic cells. Cornea. 2002;21:62\u20137.","journal-title":"Cornea"},{"key":"1094_CR28","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/j.1365-2222.2005.02285.x","volume":"35","author":"A Solomon","year":"2005","unstructured":"Solomon A, Wajngarten M, Alviano F, et al. Suppression of inflammatory and fibrotic responses in allergic inflammation by the amniotic membrane stromal matrix. Clin Exp Allergy. 2005;35:941\u20138.","journal-title":"Clin Exp Allergy"},{"key":"1094_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1542-0124(12)70059-9","volume":"2","author":"SC Tseng","year":"2004","unstructured":"Tseng SC, Espana EM, Kawakita T, et al. How does amniotic membrane work? Ocul Surf. 2004;2:177\u201387.","journal-title":"Ocul Surf"},{"key":"1094_CR30","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1089\/ten.tec.2008.0315","volume":"14","author":"A Hopkinson","year":"2008","unstructured":"Hopkinson A, Shanmuganathan VA, Gray T, et al. Optimization of amniotic membrane (AM) denuding for tissue engineering. Tissue Eng Part C Methods. 2008;14:371\u201381.","journal-title":"Tissue Eng Part C Methods"},{"key":"1094_CR31","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/jbm.b.35186","volume":"111","author":"Y Mao","year":"2023","unstructured":"Mao Y, Protzman NM, John N, Kuehn A, Long D, Sivalenka R, Junka RA, Shah AU, Gosiewska A, Hariri RJ, Brigido SA. An in vitro comparison of human corneal epithelial cell activity and inflammatory response on differently designed ocular amniotic membranes and a clinical case study. J Biomed Mater Res B Appl Biomater. 2023;111:684\u2013700.","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"1094_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/00003226-199901000-00013","volume":"18","author":"K Fukuda","year":"1999","unstructured":"Fukuda K, Chikama T, Nakamura M, Nishida T. Differential distribution of subchains of the basement membrane components type IV collagen and laminin among the amniotic membrane, cornea, and conjunctiva. Cornea. 1999;18:73\u20139.","journal-title":"Cornea"},{"key":"1094_CR33","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1167\/iovs.03-0952","volume":"45","author":"K Endo","year":"2004","unstructured":"Endo K, Nakamura T, Kawasaki S, Kinoshita S. Human amniotic membrane, like corneal epithelial basement membrane, manifests the alpha5 chain of type IV collagen. Invest Ophthalmol Vis Sci. 2004;45:1771\u20134.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1094_CR34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1167\/iovs.03-0752","volume":"45","author":"T Nakamura","year":"2004","unstructured":"Nakamura T, Yoshitani M, Rigby H, et al. Sterilized, freeze-dried amniotic membrane: a useful substrate for ocular surface reconstruction. Investig Ophthalmol Vis Sci. 2004;45:93\u20139.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1094_CR35","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1016\/j.biomaterials.2008.05.023","volume":"29","author":"T Nakamura","year":"2008","unstructured":"Nakamura T, Sekiyama E, Takaoka M, et al. The use of trehalosetreated freeze-dried amniotic membrane for ocular surface reconstruction. Biomaterials. 2008;29:3729\u201337.","journal-title":"Biomaterials"},{"key":"1094_CR36","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1001\/archopht.120.6.783","volume":"120","author":"M Grueterich","year":"2002","unstructured":"Grueterich M, Tseng SC. Human limbal progenitor cells expanded on intact amniotic membrane ex vivo. Arch Ophthalmol. 2002;120:783\u201390.","journal-title":"Arch Ophthalmol"},{"key":"1094_CR37","first-page":"878","volume":"40","author":"D Meller","year":"1999","unstructured":"Meller D, Tseng SC. Conjunctival epithelial cell differentiation on amniotic membrane. Invest Ophthalmol Vis Sci. 1999;40:878\u201386.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1094_CR38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3341\/kjo.2021.0095","volume":"36","author":"CM Choi","year":"2022","unstructured":"Choi CM, Jeon HS. Clinical outcomes of in-office sutureless amniotic membrane transplantation in persistent epithelial defect. Korean J Ophthalmol. 2022;36:87\u201396.","journal-title":"Korean J Ophthalmol"},{"key":"1094_CR39","first-page":"787","volume":"20","author":"CB Cosar","year":"2001","unstructured":"Cosar CB, Cohen EJ, Rapuano CJ, et al. Tarsorrhaphy: clinical experience from a cornea practice. Cornea J Cornea Extern Dis. 2001;20:787\u201391.","journal-title":"Cornea J Cornea Extern Dis"},{"key":"1094_CR40","first-page":"237","volume":"3","author":"A Kasaee","year":"2010","unstructured":"Kasaee A, Musavi MR, Tabatabaie SV, et al. Evaluation of efficacy and safety of botulinum toxin type A injection in patients requiring temporary tarsorrhaphy to improve corneal epithelial defects. Int J Ophthalmol. 2010;3:237\u201340.","journal-title":"Int J Ophthalmol"},{"key":"1094_CR41","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.3390\/app12083924","volume":"12","author":"A Meduri","year":"2022","unstructured":"Meduri A, Valastro A, Inferrera L, Oliverio GW, Ninotta I, Camellin U, Mancini M, Roszkowska AM, Aragona P. Sutureless amniotic membrane transplantation in inflammatory corneal perforations. Appl Sci. 2022;12:3924.","journal-title":"Appl Sci"},{"issue":"607","key":"1094_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120924","volume":"25","author":"M Mofidfar","year":"2021","unstructured":"Mofidfar M, Abdi B, Ahadian S, Mostafavi E, Desai TA, Abbasi F, Sun Y, Manche EE, Ta CN, Flowers CW. Drug delivery to the anterior segment of the eye: a review of current and future treatment strategies. Int J Pharm. 2021;25(607): 120924.","journal-title":"Int J Pharm"},{"issue":"18","key":"1094_CR43","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.2147\/OPTH.S458715","volume":"13","author":"S Trav\u00e9-Huarte","year":"2024","unstructured":"Trav\u00e9-Huarte S, Wolffsohn JS. Bilateral sutureless application of human dehydrated amniotic membrane with a specialised bandage contact lens for moderate-to-severe dry eye disease: a prospective study with 1-month follow-up. Clin Ophthalmol. 2024;13(18):1329\u201339.","journal-title":"Clin Ophthalmol"},{"key":"1094_CR44","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/ICL.0b013e3181a66a12","volume":"35","author":"P Prasher","year":"2009","unstructured":"Prasher P, Di Pascuale MA, et al. Evaluation of the role of ProKera in the management of ocular surface and orbital disorders. Eye Contact Lens. 2009;35:172\u20135.","journal-title":"Eye Contact Lens"},{"key":"1094_CR45","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/ICL.0b013e3181a66a12","volume":"35","author":"G Pachigolla","year":"2009","unstructured":"Pachigolla G, Prasher P, Di Pascuale MA, et al. Evaluation of the role of ProKera in the management of ocular surface and orbital disorders. Eye Contact Lens. 2009;35:172\u20135.","journal-title":"Eye Contact Lens"},{"key":"1094_CR46","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.1167\/iovs.14-14593","volume":"55","author":"C Giannikas","year":"2014","unstructured":"Giannikas C, Udell IJ, Steiner A, et al. Sutureless amniotic membrane transplantation for ocular surface disorders: a comparison of Prokera to AmbioDisc. Invest Ophthalmol Vis Sci. 2014;55:4707.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1094_CR47","first-page":"272","volume":"4","author":"Y Huang","year":"2013","unstructured":"Huang Y, Sheha H, Tseng SCG. Self-retained amniotic membrane for recurrent corneal erosion. J Clin Exp Ophthalmol. 2013;4:272.","journal-title":"J Clin Exp Ophthalmol"},{"key":"1094_CR48","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4103\/tjo.tjo_67_20","volume":"11","author":"SCG Tseng","year":"2020","unstructured":"Tseng SCG. Letter to the editor: PROKERA\u00ae slim corneal bandage now approved in Taiwan for treatment of corneal diseases. Taiwan J Ophthalmol. 2020;11:202\u20133.","journal-title":"Taiwan J Ophthalmol"},{"key":"1094_CR49","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.4103\/IJO.IJO_2778_22","volume":"71","author":"S Chaudhary","year":"2023","unstructured":"Chaudhary S, Ghimire D, Basu S, Agrawal V, Jacobs DS, Shanbhag SS. Contact lenses in dry eye disease and associated ocular surface disorders. Indian J Ophthalmol. 2023;71:1142\u201353.","journal-title":"Indian J Ophthalmol"},{"key":"1094_CR50","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.clae.2010.06.004","volume":"33","author":"SJ Blackmore","year":"2010","unstructured":"Blackmore SJ. The use of contact lenses in the treatment of persistent epithelial defects. Cont Lens Anterior Eye. 2010;33:239\u201344.","journal-title":"Cont Lens Anterior Eye"},{"key":"1094_CR51","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/00006324-200001000-00012","volume":"77","author":"CG Begley","year":"2000","unstructured":"Begley CG, Caffery B, Nichols KK, Chalmers R. Responses of contact lens wearers to a dry eye survey. Optom Vis Sci. 2000;77:40\u20136.","journal-title":"Optom Vis Sci"},{"key":"1094_CR52","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/00003226-200108000-00011","volume":"20","author":"CG Begley","year":"2001","unstructured":"Begley CG, Chalmers RL, Mitchell GL, et al. Characterization of ocular surface symptoms from optometric practices in North America. Cornea. 2001;20:610\u20138.","journal-title":"Cornea"},{"key":"1094_CR53","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1097\/00006324-199708000-00023","volume":"74","author":"MJ Doughty","year":"1997","unstructured":"Doughty MJ, Fonn D, Richter D, et al. A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada. Optom Vis Sci. 1997;74:624\u201331.","journal-title":"Optom Vis Sci"},{"key":"1094_CR54","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/00003226-200207000-00007","volume":"21","author":"JJ Nichols","year":"2002","unstructured":"Nichols JJ, Mitchell GL, Nichols KK, et al. The performance of the contact lens dry eye questionnaire as a screening survey for contact lens-related dry eye. Cornea. 2002;21:469\u201375.","journal-title":"Cornea"},{"key":"1094_CR55","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1167\/iovs.04-1294","volume":"46","author":"JJ Nichols","year":"2005","unstructured":"Nichols JJ, Ziegler C, Mitchell GL, Nichols KK. Self-reported dry eye disease across refractive modalities. Investig Ophthalmol Vis Sci. 2005;46:1911\u20134.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1094_CR56","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1046\/j.1475-1313.1995.9500004w.x","volume":"15","author":"N Pritchard","year":"1995","unstructured":"Pritchard N, Fonn D. Dehydration, lens movement and dryness ratings of hydrogel contact lenses. Ophthalmic Physiol Opt. 1995;15:281\u20136.","journal-title":"Ophthalmic Physiol Opt"},{"key":"1094_CR57","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/01.ico.0000248382.32143.86","volume":"26","author":"K Richdale","year":"2007","unstructured":"Richdale K, Sinnott LT, Skadahl E, Nichols JJ. Frequency of and factors associated with contact lens dissatisfaction and discontinuation. Cornea. 2007;26:168\u201374.","journal-title":"Cornea"},{"key":"1094_CR58","first-page":"220","volume":"64","author":"JL Schlanger","year":"1993","unstructured":"Schlanger JL. A study of contact lens failures. J Am Optom Assoc. 1993;64:220\u20134.","journal-title":"J Am Optom Assoc"},{"key":"1094_CR59","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1046\/j.1475-1313.2002.00066.x","volume":"22","author":"G Young","year":"2002","unstructured":"Young G, Veys J, Pritchard N, Coleman S. A multi-centre study of lapsed contact lens wearers. Ophthalmic Physiol Opt. 2002;22:516\u201327.","journal-title":"Ophthalmic Physiol Opt"},{"key":"1094_CR60","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/01.icu.0000512373.81749.b7","volume":"27","author":"MS Milner","year":"2017","unstructured":"Milner MS, Beckman KA, Luchs JI, Allen QB, Awdeh RM, Berdahl J, et al. Dysfunctional tear syndrome: dry eye disease and associated tear film disorders\u2014new strategies for diagnosis and treatment. Curr Opin Ophthalmol. 2017;27:3\u201347.","journal-title":"Curr Opin Ophthalmol"},{"key":"1094_CR61","first-page":"1","volume":"8","author":"AB Zimmerman","year":"2016","unstructured":"Zimmerman AB, Nixon AD, Rueff EM. Contact lens associated microbial keratitis: practical considerations for the optometrist. Clin Optom (Auckl). 2016;8:1\u201312.","journal-title":"Clin Optom (Auckl)"},{"key":"1094_CR62","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1097\/00140068-200301001-00024","volume":"29","author":"F Stapleton","year":"2003","unstructured":"Stapleton F. Contact lens-related microbial keratitis: what can epidemiologic studies tell us? Eye Contact Lens. 2003;29:S85\u20139 (discussion S115\u20138, S92-4).","journal-title":"Eye Contact Lens"},{"key":"1094_CR63","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0002-9394(14)72381-5","volume":"111","author":"S MacRae","year":"1991","unstructured":"MacRae S, Herman C, Stulting RD, et al. Corneal ulcer and adverse reaction rates in premarket contact lens studies. Am J Ophthalmol. 1991;111:457\u201365.","journal-title":"Am J Ophthalmol"},{"key":"1094_CR64","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1167\/iovs.09-4593","volume":"51","author":"C Tam","year":"2010","unstructured":"Tam C, Mun JJ, Evans DJ, Fleiszig SM. The impact of inoculation parameters on the pathogenesis of contact lens-related infectious keratitis. Invest Ophthalmol Vis Sci. 2010;51:3100\u20136.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1094_CR65","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1097\/01.opx.0000250045.85499.55","volume":"83","author":"SM Fleiszig","year":"2006","unstructured":"Fleiszig SM. The Glenn A. Fry award lecture 2005. The pathogenesis of contact lens-related keratitis. Optom Vis Sci. 2006;83:866\u201373.","journal-title":"Optom Vis Sci"},{"key":"1094_CR66","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1167\/iovs.10-6125","volume":"52","author":"I Alarcon","year":"2011","unstructured":"Alarcon I, Tam C, Mun JJ, et al. Factors impacting corneal epithelial barrier function against Pseudomonas aeruginosa traversal. Investig Ophthalmol Vis Sci. 2011;52:1368\u201377.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1094_CR67","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.ophtha.2008.04.002","volume":"115","author":"F Stapleton","year":"2008","unstructured":"Stapleton F, Keay L, Edwards K, et al. The incidence of contact lens\u2013related microbial keratitis in Australia. Ophthalmology. 2008;115:1655\u201362.","journal-title":"Ophthalmology"},{"key":"1094_CR68","first-page":"125","volume":"16","author":"TJ Liesegang","year":"1997","unstructured":"Liesegang TJ. Contact lens\u2013related microbial keratitis: part I: epidemiology. Cornea. 1997;16:125\u201331.","journal-title":"Cornea"},{"key":"1094_CR69","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1001\/archopht.1994.01090140062024","volume":"112","author":"OD Schein","year":"1994","unstructured":"Schein OD, Buehler PO, Stamler JF, et al. The impact of overnight wear on the risk of contact lens\u2013associated ulcerative keratitis. Arch Ophthalmol. 1994;112:186\u201390.","journal-title":"Arch Ophthalmol"},{"key":"1094_CR70","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1056\/NEJM198909213211201","volume":"321","author":"OD Schein","year":"1989","unstructured":"Schein OD, Glynn RJ, Poggio EC, Microbial Keratitis Study Group, et al. The relative risk of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. A case-control study. N Engl J Med. 1989;321:773\u20138.","journal-title":"N Engl J Med"},{"key":"1094_CR71","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1051\/parasite\/2015010","volume":"22","author":"J Lorenzo-Morales","year":"2015","unstructured":"Lorenzo-Morales J, Khan NA, Walochnik J. An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment. Parasite. 2015;22:10.","journal-title":"Parasite"},{"key":"1094_CR72","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.survophthal.2023.06.001","volume":"68","author":"ZZ Thia","year":"2023","unstructured":"Thia ZZ, Ho YT, Shih KC, Tong L. New developments in the management of persistent corneal epithelial defects. Surv Ophthalmol. 2023;68:1093\u2013114.","journal-title":"Surv Ophthalmol"},{"key":"1094_CR73","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.ajo.2013.06.006","volume":"156","author":"P Lim","year":"2013","unstructured":"Lim P, Ridges R, Jacobs DS, Rosenthal P. Treatment of persistent corneal epithelial defect with overnight wear of a prosthetic device for the ocular surface. Am J Ophthalmol. 2013;156:1095\u2013101.","journal-title":"Am J Ophthalmol"},{"key":"1094_CR74","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/01.icl.0000182488.70745.1d","volume":"31","author":"D Fonn","year":"2005","unstructured":"Fonn D, Bruce AS. A review of the Holden\u2013Mertz criteria for critical oxygen transmission. Eye Contact Lens. 2005;31:247\u201351.","journal-title":"Eye Contact Lens"},{"key":"1094_CR75","first-page":"264","volume":"47","author":"CA Flynn","year":"1998","unstructured":"Flynn CA, D\u2019Amico F, Smith G. Should we patch corneal abrasions? A meta-analysis J Fam Pract. 1998;47:264\u201370.","journal-title":"A meta-analysis J Fam Pract"},{"key":"1094_CR76","first-page":"CD004764","volume":"26","author":"CH Lim","year":"2016","unstructured":"Lim CH, Turner A, Lim BX. Patching for corneal abrasion. Cochrane Database Syst Rev. 2016;26:CD004764.","journal-title":"Cochrane Database Syst Rev"},{"key":"1094_CR77","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0301-2115(00)00345-6","volume":"94","author":"N Kjaergaard","year":"2001","unstructured":"Kjaergaard N, Hein M, Hyttel L, et al. Antibacterial properties of human amnion and chorion in vitro. Eur J Obstet Gynecol Reprod Biol. 2001;94:224\u20139.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1094_CR78","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.3390\/ijms22041901","volume":"22","author":"B Jones","year":"2021","unstructured":"Jones B, Li C, Park MS, Lerch A, Jacob V, Johnson N, Kuang JQ, Dhall S, Sathyamoorthy M. Comprehensive comparison of amnion stromal cells and chorion stromal cells by RNA-Seq. Int J Mol Sci. 2021;22:1901.","journal-title":"Int J Mol Sci"},{"key":"1094_CR79","doi-asserted-by":"publisher","first-page":"13007","DOI":"10.1038\/s41598-021-92366-x","volume":"11","author":"DSJ Ting","year":"2021","unstructured":"Ting DSJ, Henein C, Said DG, et al. Amniotic membrane transplantation for infectious keratitis: a systematic review and meta-analysis. Sci Rep. 2021;11:13007.","journal-title":"Sci Rep"},{"key":"1094_CR80","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3341\/kjo.2015.29.1.73","volume":"29","author":"MK Yang","year":"2015","unstructured":"Yang MK, Kim MK, Kim DM. Amniotic membrane transplantation for repair of a large intraoperative conjunctival defect during trabeculectomy. Korean J Ophthalmol. 2015;29:73\u20134.","journal-title":"Korean J Ophthalmol"},{"issue":"343","key":"1094_CR81","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1056\/NEJM200007133430202","volume":"13","author":"RJ Tsai","year":"2000","unstructured":"Tsai RJ, Li LM, Chen JK. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N Engl J Med. 2000;13(343):86\u201393.","journal-title":"N Engl J Med"},{"issue":"8","key":"1094_CR82","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.2147\/OPTH.S55259","volume":"13","author":"JD Sheppard","year":"2014","unstructured":"Sheppard JD, Mansur A, Comstock TL, Hovanesian JA. An update on the surgical management of pterygium and the role of loteprednol etabonate ointment. Clin Ophthalmol. 2014;13(8):1105\u201318.","journal-title":"Clin Ophthalmol"},{"issue":"17","key":"1094_CR83","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.2147\/OPTH.S410452","volume":"11","author":"P Rivera-Morales","year":"2023","unstructured":"Rivera-Morales P, Barnard L, Linderman W, Gill M, Diaz V. Surgical time and postoperative symptoms study in pterygium excision and amniotic membrane graft using celularity triple layer dehydrated amniotic membrane. Clin Ophthalmol. 2023;11(17):1967\u201374.","journal-title":"Clin Ophthalmol"},{"key":"1094_CR84","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/eye.2014.148","volume":"28","author":"M Palamar","year":"2014","unstructured":"Palamar M, Kaya, E, Egrilmez S et al. Amniotic membrane transplantation in surgical management of ocular surface squamous neoplasias: long-term results. Eye 2014;28, 1131\u20131135.","journal-title":"Eye (Long)"},{"key":"1094_CR85","doi-asserted-by":"crossref","unstructured":"Wu M, Zhang R, Zou Q, Chen Y, Zhou M, Li X, Ran R, Chen Q. Comparison of the Biological Characteristics of Mesenchymal Stem Cells Derived from the Human Placenta and Umbilical Cord. Sci. Rep. 2018;8:1\u20139.","DOI":"10.1038\/s41598-018-23396-1"},{"key":"1094_CR86","doi-asserted-by":"crossref","unstructured":"Tighe S, Mead OG, Lee A, Tseng SCG. Basic science review of birth tissue uses in ophthalmology. Taiwan J Ophthalmol. 2020;10:3\u201312.","DOI":"10.4103\/tjo.tjo_4_20"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01094-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-025-01094-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01094-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T15:08:27Z","timestamp":1739459307000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-025-01094-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":86,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1094"],"URL":"https:\/\/doi.org\/10.1007\/s40123-025-01094-2","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]},"assertion":[{"value":"12 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Kyle Linsey has no financial or competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study protocol was reviewed by the Institutional Review Board (IRB) at Advarra, and the need for informed consent was determined to be exempt from IRB oversight. The IRB determined that the study met the criteria for a waiver because it was minimal risk to participants, used de-identified data, and was a retrospective study. Furthermore, the research adhered to the ethical standards outlined in the Declaration of Helsinki, ensuring compliance with guidelines for conducting research involving human participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}